Literature DB >> 17701128

Lymphoplasmacytic sclerosing pancreatitis forming a localized mass: a variant form of autoimmune pancreatitis.

Go Kobayashi1, Naotaka Fujita, Yutaka Noda, Kei Ito, Jun Horaguchi, Osamu Takasawa, Takashi Obana, Kazunari Nakahara, Miwa Uzuki, Takashi Sawai.   

Abstract

BACKGROUND: To elucidate the correlation of autoimmune pancreatitis (AIP) and mass-forming pancreatitis, in which a localized mass is formed in the pancreas.
METHODS: Nine cases of mass-forming pancreatitis were divided into two groups, one consisting of cases that met the histological diagnostic criteria for AIP by the Japan Pancreas Society (JPS) and the other consisting of cases which did not. Histological findings, immunohistological findings, and pancreatograms were compared between these groups.
RESULTS: Six cases met the histological criteria of JPS (group A) and the other three did not (group B). In the mass-forming portion in group A, the wall of the pancreatic duct showed marked thickening. However, the epithelium was well preserved, and dilatation of the branch ducts or protein plugs were rarely observed. All cases showed marked obliterative phlebitis. The IgG4 labeling index (LI) was 25% or more in all but one case. In the portion other than the mass, the lobular structure was well preserved and the IgG4 LI was less than 10%. The pancreatogram showed localized stenosis or obstruction at the site of the mass associated with a normal-appearing main pancreatic duct in the remaining portion. In group B, histological findings typical of chronic pancreatitis with dilated branch ducts and protein plugs were observed. Obliterative phlebitis was not confirmed. The IgG4 LI in the mass-forming portion was low (2.3%-11.1%).
CONCLUSIONS: There exists a subgroup of AIP showing localized mass formation and stenosis or obstruction of the main pancreatic duct with prominent obliterative phlebitis associated with a normal ductal segment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701128     DOI: 10.1007/s00535-007-2068-2

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  7 in total

Review 1.  Autoimmune pancreatitis: with special reference to a localized variant.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Kei Ito; Jun Horaguchi
Journal:  J Med Ultrason (2001)       Date:  2008-07-04       Impact factor: 1.314

2.  Small nodules which could indicate the early phase of autoimmune pancreatitis.

Authors:  Fumihiko Miura; Keiji Sano; Hodaka Amano; Naoyuki Toyota; Keita Wada; Makoto Shibuya; Susumu Kadowaki; Toshiaki Watanabe; Taketo Yamaguchi; Fukuo Kondo
Journal:  Clin J Gastroenterol       Date:  2011-07-12

3.  Peripancreatic vascular involvement in patients with type 1 autoimmune pancreatitis.

Authors:  Meizi Li; Xiaoyin Bai; Kai Xu; Xi Wu; Tao Guo; Qingwei Jiang; Qiang Wang; Shengyu Zhang; Yingyun Yang; Yunlu Feng; Aiming Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

4.  Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis.

Authors:  Hiroyuki Matsubayashi; Katsuhiko Uesaka; Hideyuki Kanemoto; Takeshi Aramaki; Yoshihiro Nakaya; Naomi Kakushima; Hiroyuki Ono
Journal:  J Gastroenterol       Date:  2012-10-18       Impact factor: 7.527

5.  A variant form of autoimmune pancreatitis successfully treated by steroid therapy, accompanied by von Meyenburg complex.

Authors:  Hideaki Miura; Shigehiro Kitamura; Haruki Yamada
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

6.  Clinical analysis of 36 cases of autoimmune pancreatitis in China.

Authors:  Xingang Zhang; Xinpeng Zhang; Wei Li; Li Jiang; Xiaoli Zhang; Yun Guo; Xiaofei Wang
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Branch Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas Involving Type 1 Localized Autoimmune Pancreatitis with Normal Serum IgG4 Levels Successfully Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration and Treated without Pancreatic Surgery.

Authors:  Shinsuke Koshita; Yutaka Noda; Kei Ito; Yoshihide Kanno; Takahisa Ogawa; Kaori Masu; Yoshiharu Masaki; Hiroaki Kusunose; Toshitaka Sakai; Toji Murabayashi; Sho Hasegawa; Fumisato Kozakai; Jun Horaguchi; Takashi Sawai
Journal:  Intern Med       Date:  2017-05-15       Impact factor: 1.271

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.